Earnings · China A-shares
PharmaBlock Sciences (Nanjing), Inc. Class A (300725) earnings
PharmaBlock Sciences (Nanjing), Inc. Class A published its Q3 report on 2026-10-29: net profit +33.36% year on year, +44.87% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved +0.52% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-29
- Period end
- 2026-09-30
- Net profit YoY
- +33.36%
- Excl. one-offs YoY
- +44.87%
- Net profit QoQ
- +2.40%
- Result
- Good
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +4.92% | — |
| 3 days | +0.52% | — |
| 7 days | +8.38% | — |
| 14 days | -6.18% | — |
Report history
Over the last 8 reports, net profit grew year on year in 4 of them. The stock rose in the 3 trading days after 5 of 6 reports (average +2.28%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-30 | ¥151.22M | +33.36% | +44.87% | +15.16% | 0.65 | 2.77% | +0.52% | — | — |
| 2026 interim report | 2026-08-11 | ¥99.44M | +37.17% | +40.70% | +15.19% | 0.43 | 1.82% | +10.44% | +1.64% | +4.80% |
| 2026 Q1 report | 2026-04-22 | ¥48.89M | +36.59% | +26.91% | +11.65% | 0.21 | 0.83% | +0.50% | -12.48% | -14.07% |
| 2025 annual report | 2026-04-22 | ¥183.74M | -16.31% | -16.24% | +16.93% | 0.88 | 4.17% | +0.50% | -12.48% | -14.07% |
| 2025 Q3 report | 2025-10-30 | ¥113.39M | -13.96% | +0.49% | +25.81% | 0.56 | 2.48% | +1.64% | -8.48% | -3.74% |
| 2025 interim report | 2025-08-08 | ¥72.50M | -26.54% | -11.82% | +23.48% | 0.36 | 2.18% | -0.99% | -5.64% | -15.03% |
| 2025 Q1 report | 2025-04-25 | ¥35.79M | -27.67% | -26.29% | +20.55% | 0.18 | 1.19% | +1.59% | +15.00% | +11.75% |
| 2024 annual report | 2025-04-25 | ¥219.54M | +11.24% | -1.66% | -2.12% | 1.10 | 7.56% | +1.59% | +15.00% | +11.75% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.